Dear Editor
Since December 2019, the coronavirus has affected all aspects of our lives worldwide. This deadly crisis, for which no health care system was fully prepared, has created enormous pressures on health care delivery and has directly and indirectly affected the treatment of many common diseases. Cancer patients are a vulnerable group in the current epidemic due to their immunodeficiency status due to cancer and various anti-cancer therapies [1]. Research shows that cancer patients are at greater risk for more severe infections and subsequent complications, especially if surgery or chemotherapy is given in the month before the coronavirus infection [2]. These conditions have led to a significant increase in coronavirus mortality in cancer patients [3].